HealthEquity, Inc. (NASDAQ:HQY) is Aristotle Capital Boston LLC's 8th Largest Position

Aristotle Capital Boston LLC grew its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 573,441 shares of the company's stock after acquiring an additional 35,128 shares during the quarter. HealthEquity comprises about 2.0% of Aristotle Capital Boston LLC's portfolio, making the stock its 8th largest position. Aristotle Capital Boston LLC owned 0.66% of HealthEquity worth $55,022,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Ameritas Investment Partners Inc. raised its holdings in shares of HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after purchasing an additional 88 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares in the last quarter. Louisiana State Employees Retirement System lifted its holdings in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund increased its holdings in shares of HealthEquity by 0.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after acquiring an additional 100 shares during the period. Finally, State of Michigan Retirement System raised its position in shares of HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on HQY. KeyCorp cut their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. The Goldman Sachs Group reduced their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Barrington Research restated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $111.75.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 20,381 shares of company stock valued at $1,781,432 in the last quarter. 2.20% of the stock is currently owned by company insiders.

HealthEquity Stock Performance

Shares of NASDAQ:HQY traded up $0.90 during midday trading on Thursday, reaching $92.62. The company's stock had a trading volume of 347,100 shares, compared to its average volume of 783,490. The stock has a fifty day moving average of $88.57 and a 200 day moving average of $96.58. The firm has a market capitalization of $8.01 billion, a PE ratio of 84.97, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.